NCT03457441

Brief Summary

This study evaluates the level of agreement between visual parameters tested using OdySight, a mobile application, and standards in office methods.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 7, 2018

Completed
13 days until next milestone

Study Start

First participant enrolled

March 20, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 24, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 24, 2018

Completed
Last Updated

July 27, 2018

Status Verified

July 1, 2018

Enrollment Period

4 months

First QC Date

February 20, 2018

Last Update Submit

July 26, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Near visual acuity assessment with OdySight versus with near visual acuity chart

    To assess the equivalence between a smartphone based evaluation of near visual acuity with ODYSIGHT (NVA module) and a standardized method (Sloan ETDRS near vision letter chart).

    1 day ( During evaluation visit)

Secondary Outcomes (1)

  • Near visual acuity assessment with OdySight versus with ETDRS chart

    1 day ( During evaluation visit)

Other Outcomes (3)

  • Contrast sensitivity assessment with OdySight versus with Pelli-Robson

    1 day ( During evaluation visit)

  • Scotoma/metamorphopsia detection with OdySight versus with standard Amsler grid

    1 day ( During evaluation visit)

  • Global functional disorders assessment with Odysight versus with OCT

    1 day ( During evaluation visit)

Study Arms (3)

Near visual acuity +1.0 and +0.7 logMAR

OTHER

Subjects with near visual acuity between +1.0 and +0.7 logMAR , when eligible and providing informed consent, assigned to evaluation with OdySight mobile medical application

Other: Standards vision testsDevice: OdySight medical application assessment

Near visual acuity +0.6 and +0.3 logMAR

OTHER

Subjects with near visual acuity between +0.6 and +0.3 logMAR , when eligible and providing informed consent, assigned to evaluation with OdySight mobile medical application

Other: Standards vision testsDevice: OdySight medical application assessment

Near visual acuity +0.2 and +0.0 logMAR

OTHER

Subjects with near visual acuity between +0.2 and +0.0 logMAR , when eligible and providing informed consent, assigned to evaluation with OdySight mobile medical application

Other: Standards vision testsDevice: OdySight medical application assessment

Interventions

Subjects vision : near visual acuity, contrast sensitivity and scotoma and metamorphopsia detection will be assessed by gold-standard tests and with the OdySight medical application

Near visual acuity +0.2 and +0.0 logMARNear visual acuity +0.6 and +0.3 logMARNear visual acuity +1.0 and +0.7 logMAR

Subjects vision : near visual acuity, contrast sensitivity and scotoma and metamorphopsia detection will be assessed by gold-standard tests and with the OdySight medical application

Near visual acuity +0.2 and +0.0 logMARNear visual acuity +0.6 and +0.3 logMARNear visual acuity +1.0 and +0.7 logMAR

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Able to correctly distinguish the body laterality (left and right)
  • Able to recognize alphabet letters and read French
  • Affiliated to or beneficiary of the French health care system
  • Signed/written informed consent
  • Subject presenting a level of visual acuity of one of his eyes that fits to one of the pre-set cohort (visual acuity between +1.0 and +0.7 logMAR, between +0.6 and +0.3 logMAR or between +0.2 and 0.0 logMAR); the two eyes can be included in two different cohorts.

You may not qualify if:

  • Any pathology that is considered by the investigator as capable of affecting the quality of the main evaluation criteria.
  • Pregnant and breastfeeding women.
  • Subject not considered by the investigator or designee to correctly use OdySight modules after the training session

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier National d'Ophtahlomogie du Quinze-Vingts

Paris, Île-de-France Region, 75012, France

Location

Related Publications (1)

  • Brucker J, Bhatia V, Sahel JA, Girmens JF, Mohand-Said S. Odysight: A Mobile Medical Application Designed for Remote Monitoring-A Prospective Study Comparison with Standard Clinical Eye Tests. Ophthalmol Ther. 2019 Sep;8(3):461-476. doi: 10.1007/s40123-019-0203-9. Epub 2019 Jul 25.

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Saddek Mohan-Saïd, MD

    Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2018

First Posted

March 7, 2018

Study Start

March 20, 2018

Primary Completion

July 24, 2018

Study Completion

July 24, 2018

Last Updated

July 27, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations